XTL Biopharmaceuticals Ltd (XTLB)
2.42
0.00 (0.00%)
USD |
NASDAQ |
Apr 29, 16:00
2.59
+0.17
(+7.02%)
After-Hours: 05:08
XTL Biopharmaceuticals Cash from Investing (TTM)
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
| Date | Value |
|---|---|
| December 31, 2014 | 1.499M |
| September 30, 2014 | 0.038M |
| June 30, 2014 | 3.654M |
| March 31, 2014 | 3.113M |
| December 31, 2013 | 3.336M |
| September 30, 2013 | 3.552M |
| June 30, 2013 | -0.07M |
| March 31, 2013 | -1.688M |
| December 31, 2012 | -1.209M |
| September 30, 2012 | -1.463M |
| June 30, 2012 | -1.473M |
| Date | Value |
|---|---|
| March 31, 2012 | 1.461M |
| December 31, 2011 | -1.372M |
| September 30, 2011 | |
| June 30, 2011 | |
| March 31, 2011 | |
| December 31, 2010 | |
| September 30, 2010 | -0.055M |
| June 30, 2010 | -0.055M |
| March 31, 2010 | -0.05M |
| December 31, 2009 | -0.024M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| Compugen Ltd | -- |
| Pluri Inc | 12.36M |
| BioLine Rx Ltd | 1.444M |
| Can Fite Biofarma Ltd | -- |
| BiomX Inc | 1.951M |